Invisible Sentinel Launches Vibrio Parahaemolyticus Assay | Veriflow Product Line To Detect Foodborne Pathogens Continues Expansion with Assay for Shellfish

June 1, 2017

Philadelphia, Pennsylvania, - Invisible Sentinel Inc., a Philadelphia-based global molecular solutions company announced today that its Veriflow technology platform for the detection of Vibrio parahaemolyticus organisms in shellfish has completed validation.

Vibrio parahaemolyticus species present a significant health risk and causes acute illness following the consumption of contaminated shellfish. Current methods for detection are cumbersome and inefficient. Veriflow Vibrio is a rapid, sensitive, and easy-to-use method that is robust enough for use in various seafood matrices.

The assay is currently being implemented by several large seafood manufacturers and is available domestically through Invisible Sentinel and internationally via distribution partners.

Invisible Sentinel has also developed a suite of detection tools for spoilage organisms in wine, beer, and juice. Veriflow® Vibrio and other assays are available directly from Invisible Sentinel. For ordering information or quotations, please call the Invisible Sentinel customer service team at 215-966-6118.

About Invisible Sentinel
Invisible Sentinel is the inventor of Veriflow® technology, a patented, molecular flow-based technology that draws from the company’s core competencies in molecular diagnostics, antibody design, and immunoassays. Veriflow® test kits are currently applied across multiple industries. Invisible Sentinel helps the food industry to detect foodborne pathogens and works with winemakers and beer artisans to cost-effectively improve the quality of their products. The company designs custom solutions utilizing the Veriflow technology for other industries including healthcare, veterinary services, biodefense, and environmental testing. Each solution is specific, but each retains the inherent advantages of Veriflow® technology—it’s simple, accessible, and affordable.

Back to News >